You can get an at-home flu ‘shot’ begining next year

The Food and Drug Administration has apshowd a nasassociate-deal withed influenza immunization treatment that can be getn at home. FluMist — a nasal spray vaccine that AstraZeneca initiassociate prolonged as an in-office treatment two decades ago — will still demand a prescription to acquire and is anticipateed to be made engageable via a new online pharmacy next year, according to The New York Times.

The treatment will demand people to fill out a inquirenaire on the upcoming FlueMist Home website. Once apshowd by a pharmacist, the nasal spray will be shipped honestly to the customer’s door. The current out-of-pocket cost is around $35 to $45 per dose according to the NYT, but that may drop depfinishing on insurance coverage.

The Cgo ins for Disrelieve Control and Prevention set up that FluMist has a aenjoy efficacy to the traditional shot. It has been engageable thcdisesteemful healthnurture supplyrs ever since it was first apshowd by the FDA back in 2003. It’s fitting for people aged between 2 to 49 years ageder — though the FDA recommfinishs that the nasal spray be deal withed by a parent/nurturedonater to anyone under 18. The spray could be an alternative for people who are averse to getting injections, or otherteachd discover it difficult or inhandy to travel for flu immunization treatments.

“Today’s approval of the first influenza vaccine for self- or nurturedonater-administration supplys a new chooseion for receiving a shielded and effective seasonal influenza vaccine potentiassociate with fantasticer convenience, flexibility and accessibility for individuals and families,” shelp the FDA’s vaccine cgo in honestor, Dr. Peter Marks. The World Health Organization inestablishs that there are around a billion annual cases of seasonal influenza, resulting in 290,000 to 650,000 respiratory deaths each year.